Oral administration of Escherichia coli in enteric coated microparticles induces serum antibodies against lipopolysaccharide antigens

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Endotoxin Research

• Publication date

  1996-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1177/096805199600300606
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Development

  1996cited by this paper
• Immunologic effects of encapsulated short ragweed extract: a potent new agent for oral immunotherapy.

  1996cited by this paper
• Activation patterns of murine T cells after oral administration of an enterocoated soluble antigen.

  1996cited by this paper
• Development of oral vaccines to stimulate mucosal and systemic immunity: barriers and novel strategies.

  1995cited by this paper
• Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.

  1994cited by this paper
• Oral immunization: turning fantasy into reality.

  1994cited by this paper
• Oral Vaccine Models: Multiple Delivery Systems Employing Tetanus Toxoid a

  1994cited by this paper
• Oral Vaccine Models: Multiple Delivery Systems Employing Tetanus Toxoid a

  1994cited by this paper
• New strategies for using mucosal vaccination to achieve more effective immunization.

  1994cited by this paper
• Potential of polymer microencapsulation technology for vaccine innovation.

  1994cited by this paper
• Evaluation of different immunization schedules for oral cholera B subunit-whole cell vaccine in Swedish volunteers.

  1993cited by this paper
• Oral immunization with influenza virus in biodegradable microspheres.

  1993cited by this paper
• Prevention of renal scarring from pyelonephritis in nonhuman primates by vaccination with a synthetic Escherichia coli serotype O8 oligosaccharide-protein conjugate

  1993cited by this paper
• Intestinal antibody response after oral immunization with a prototype cholera B subunit-colonization factor antigen enterotoxigenic Escherichia coli vaccine.

  1993cited by this paper
• Immunogenicity and efficacy of oral or intranasal Shigella flexneri 2a and Shigella sonnei proteosome-lipopolysaccharide vaccines in animal models

  1993cited by this paper
• Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids

  1993cited by this paper
• Interactions of microorganisms with intestinal M cells: mucosal invasion and induction of secretory immunity.

  1993cited by this paper
• Immunization of rabbits with enterotoxigenic E. coli colonization factor antigen (CFA/I) encapsulated in biodegradable microspheres of poly (lactide-co-glycolide).

  1993cited by this paper
• Killed Campylobacter elicits immune response and protection when administered with an oral adjuvant.

  1993cited by this paper
• Pili in microspheres protect rabbits from diarrhoea induced by E. coli strain RDEC-1.

  1993cited by this paper
• New perspectives in vaccine development: mucosal immunity to infections.

  1993cited by this paper
• Protection of mice against Salmonella typhimurium with an O-specific polysaccharide-protein conjugate vaccine

  1992cited by this paper
• The mucosal immune system: from fundamental concepts to vaccine development.

  1992cited by this paper
• Hypothesis for vaccine development: protective immunity to enteric diseases caused by nontyphoidal salmonellae and shigellae may be conferred by serum IgG antibodies to the O-specific polysaccharide of their lipopolysaccharides.

  1992cited by this paper
• Safety and immunogenicity of an oral recombinant cholera B subunit-whole cell vaccine in Swedish volunteers.

  1992cited by this paper
• Selective induction of Th2 cells in murine Peyer's patches by oral immunization.

  1992cited by this paper
• Oral Delivery of Vaccines

  1992cited by this paper
• Safety and immunogenicity of Escherichia coli O18 O-specific polysaccharide (O-PS)-toxin A and O-PS-cholera toxin conjugate vaccines in humans.

  1991cited by this paper
• Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid

  1991cited by this paper
• Biodegradable microspheres as a vaccine delivery system.

  1991cited by this paper
• Strategies for exploiting the immune system in the design of vaccines.

  1991cited by this paper
• Comparison of the human immune response to live oral, killed oral or killed parenteral Salmonella typhi TY21A vaccines.

  1991cited by this paper
• Oral vaccines: Design and delivery

  1991cited by this paper
• Intestinal translocation of particulates — implications for drug and antigen delivery

  1990cited by this paper
• Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches

  1990cited by this paper
• BIOADHESIVE POLYMER SYSTEMS FOR PEPTIDE DELIVERY

  1990cited by this paper
• Antibody-secreting cells in the evaluation of the immunogenicity of an oral vaccine.

  1990cited by this paper
• TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

  1989cited by this paper
• Use of hybridoma immunoglobulin switch variants in the analysis of the protective properties of anti-lipopolysaccharide antibodies in Escherichia coli K1 infection.

  1989cited by this paper
• Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies.

  1989cited by this paper
• The role of digestive enzymes in orally induced immune tolerance.

  1989cited by this paper
• The role of digestive enzymes in orally induced immune tolerance.

  1989cited by this paper
• The regulation of immune responses to dietary protein antigens.

  1987cited by this paper
• Efficacy of oral immunization against non-typable Haemophilus influenzae in man.

  1987cited by this paper
• Potent adjuvant action of lipopolysaccharides possessing the O-specific polysaccharide moieties consisting of mannans in antibody response against protein antigen.

  1985cited by this paper
• Specific adherence of Escherichia coli (strain RDEC-1) to membranous (M) cells of the Peyer's patch in Escherichia coli diarrhea in the rabbit.

  1983cited by this paper
• A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels.

  1982cited by this paper
• Protective Effect of Active Immunization with Purified Escherichia coli Heat-Labile Enterotoxin in Rats

  1979cited by this paper
• Lipopolysaccharide-lipid a associated protein (lap) complexes. I. Chemical and biological properties of lap. Abstr.

  1977cited by this paper
• Adjuvant and immunogenic properties of bacterial lipopolysaccharide in IgE and IgG antibody formation in mice.

  1976cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Serum antibody response induced in mice after oral administration of three different antigens of enterotoxigenic Escherichia coli in enteric coated microparticles.

  2006cites this paper
• Development of an enteric-coated pellet formulation of F4 fimbriae for oral vaccination of suckling piglets against enterotoxigenic Escherichia coli infections.

  2005cites this paper
• Considerations for development of whole cell bacterial vaccines to prevent diarrheal diseases in children in developing countries.

  2005cites this paper
• Sub-compartmentalization of the gastrointestinal (GI) immune system determined with microbeads that differ in release properties.

  2004cites this paper
• POTENTIAL BENEFIT FROM INACTIVATED WHOLE CELL VACCINES

  2003cites this paper
• Biological activity of lipopolysaccharides of gram-negative bacteria

  2000cites this paper
• Oral immunization with a Streptococcal pneumoniae polysaccharide conjugate vaccine in enterocoated microparticles induces serum antibodies against type specific polysaccharides.

  1999cites this paper